Effect of antenatal betamethasone and dexamethasone administration on fetal heart rate variability in growth-retarded fetuses

Fetal Diagnosis and Therapy

Volumn 12, Issue 3, 1997, Pages 170-177

  Mutton, Olivier ^a   Sénat, Marie Victoire ^a   Minoui, Sepanda ^a   Hue, Marie Véronique ^a   Frydman, René ^a   Ville, Yves ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Corticosteroids; Fetal heart rate; Intrauterine growth retardation; Variability

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE;

ARTICLE; CARDIOTOCOGRAPHY; FETUS; FETUS HEART RATE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TIME;

EID: 0030815727     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264461     Document Type: Article

References (14)

1. Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972:50:515-525.
2. Dorr HG, Versmold HT, Sippes WG, Bidling-maier F, Knorr D: Antenatal betamethasone therapy: F.tTecls on maternal, fetal, and neonatal mineralocorticoids. glucocorticoids, and progcstins. J Pediatr 1986;108:990-995.
3. Ballard PL, Granberg P, Ballard RA: Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56:1548-1554.
4. Dawes G, Serra-Serra V, Moulden M, Redman C’WG: Dexamethasonc and fetal heart rate variation. Br J Obstet Gynaecol 1994; 101;675-679.
5. Derks JB, Mulder EJH, Visser GHA: The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995; 102:40-46.
6. Ville Y, Vincent Y, Tordjmann N, Hue MV, Fernandez H, Frydman R: Effects of betamethasone on the fetal heart rate pattern assessed by computerized cardiotocography in normal twin pregnancies. Fetal Diagn Thcr 1995;10: 301-307.
7. Katz M, Meizner I, Holdberg G, Insler V: Reduction of fetal movements after steroid administration for enhancement of lung maturation: Clinical evaluation. Isr J Med Sci 1988; 24:5-9.
8. Henson GL, Dawes GS, Redman CWG: Characterization of the reduced heart rate variation in growth-retarded fetuses. Br J Obstet Gynaecol 1984;91:751-755.
9. Dawes GS, Houghton CRS, Redman CWG, Visser GHA: Pattern of the normal fetal heart rate. Br J Obstet Gynaecol 1982;8:276-284.
10. ACOG Committee: Opinion 147. December 1994.
11. NIH Consensus Development Panel: The effect of corticosteroids for fetal maturation on perinatal outcomes. National Library of Medicine, National Institutes of Health, Bethesda. Md. J Am Med Assoc 1995:273:413-418.
12. Collaborative Group on Antenatal Steroid Therapy: Effect of antenatal dexamethasonc administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141:276-287.
13. Ballard PL, Ballard RA: Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gvnccol 1995:173: 254-262.
14. Economides DL, Nicolaidcs KH, Linton EA, Perry LA, Chard T: Plasma cortisol and ACTH in appropriate and small for gestational age fetuses. Fetal Ther 1988:3:158-164.